MSLN promotes the expression of matrix metalloproteinase-7 (MMP-7) through the MAPK/ERK and JNK signaling pathways, thereby enhancing the migration and invasion of ovarian cancer cells [59]. Here, MMP7 is linked to ovarian cancer.